Pulsatile delivery of leptin receptor ligands

Details Pulsatile delivery of leptin receptor ligands Pulsatile delivery of leptin receptor ligands

1997-02-25

1999-10-12

Hutzell, Paula K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530399, A61K 3824, A01N 3718

Patent

active

059655216

ABSTRACT:
This invention provides a method for optimizing the administration of leptin receptor ligands to a mammal in need of such treatment. More specifically, this invention provides an improved method of delivering leptin receptor ligands to a mammal in need of such treatment comprising pulsatile or peak delivery of leptin receptor ligands to treat obesity and related conditions, including hyperglucocorticoidinemia, fertility or delayed puberty, and/or growth hormone deficiencies.

REFERENCES:
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4196265 (1980-04-01), Koprowski et al.
patent: 4271145 (1981-06-01), Wands
Zhang et al., "Positional Cloning of the Mouse obese gene and its human homologue" Nature (1994) 372:425-432.
Murakami et al., "Cloning of Rat OBESE cDNA and Its Expression in Obese Rats.sup.+ " Biochem. Biophys. Res Com. (1995) 209:944-952.
Douillard, I.Y. and Hoffman, T., "Basic Facts About Hybridomas", in Compendium of Immunology, vol. II, L. Schwartz (Ed.) (1981).
Kohler, G. and Milstein, C., "Continous Cultures of Fused Cells Secreting Antibody of Predefined Specificity", Nature (1975) 256: 495-497.
Kohler, G. and Milstein, C., "Derivation of Specific Antibody-Producing Tissue Culture and Tumor Lines by Cell Fusion" European Journal of Immunology (1976) 6: 511-519.
Sinha, M.K. et al. "Nocturnal Rise of Leptin in Lean, Obese, and Non-Insulin-dependent Diabetes Mellitus Subjects" (1996) J. Clin. Invest. 97: 1344-1347.
M. Rosebaum et al., "Effects of Gender, Body Composition, and Menopause on Plasma Concentrations of Leptin" (1996) J. of Clinical Endocrinology and Metabolism 81:3424-3427, No. 9.
S. Hassink, MD et al., "Serum Leptin in Children with Obesity: Relationship to Gender and Development" (1996) Pediatrics 98:201-203, No. 98.
Byrne, M.M. et al. "Elevated Plasma Glucose 2 h Postchallenge Predicts Defects in .beta.-Cell Function" Am. J. Physiol. (1996) 270:E572-579.
Stepens, T.W. et al. "The Role of Neuropeptide Y in the Antiobesity Action of the obese Gene Product"Nature (1995) 377:530-532.
Bolton, A.F. & Hunter, W.M. "The Labelling of Proteins to High Specific Radioactivities by Conjugation to a .sup.125 I-Containing Acylating Agent" Biochem. J. (1973) 133:529-539.
Van Cauter, E., & Honicky, E. "Pulsatility of Pituitary Hormones" Exp. Brain Res. (1985) 12(suppl):41-60.
Sturis, J. "Computer Model for Mechanisms Underlying Ultradian Oscillations of Insulin and Glucose" Am. J. Physiol. (1991) 260:E801-809.
MacDougald, O.A. et al. "Regulated Expression of the Obese Gene Product (leptin) in White Adipose Tissue and 3T3-L1 Adipocytes" Proc. Natl. Acad. Sci. (USA) (1995) 92:9034-9037.
Consideine, R.V., et al. "Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans" New Eng. J. Med.(1996) 334:292-295.
Maffei, M. et al. "Leptin Levels in Human and Rodent: Measurement of Plasma Leptin and ob RNA in Obese and Weight-Reduce Subjects" Nature Medicine (1995) 1:1155-1161.
Kolaczynski, J.W. et al. (1996) Diabetes 43(Supp. 1): (Abstract).
Sinha et al. Biochem Biophy. Res Comm. vol. 228 No. 3, pp. 733-738 (1996).

Affiliated with

Also associated with

Rating

Pulsatile delivery of leptin receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pulsatile delivery of leptin receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulsatile delivery of leptin receptor ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-652347